Seeing Is Believing

Currently out of the existing stock ratings of Brian Wright, 24 are a BUY (85.71%), 4 are a HOLD (14.29%).
Analyst Brian Wright, carries an average stock price target met ratio of 53% that have a potential upside of 20.02% achieved within 268 days.
Brian Wright’s has documented 55 price targets and ratings displayed on 12 stocks. The coverage was on Basic Materials, Industrials, Consumer Defensive, Healthcare sectors.
Most recent stock forecast was given on BIOX, Bioceres Crop Solutions Corp at 09-Feb-2024.
Analyst best performing recommendations are on EVGN (EVOGENE).
The best stock recommendation documented was for EVGN (EVOGENE) at 7/21/2023. The price target of $10 was fulfilled within 14 days with a profit of $1.3 (11.5%) receiving and performance score of 8.22.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 04-Jun-2019
$82
$5.69 (7.46%)
$78
10 days ago
(17-Feb-2026)
5/7 (71.43%)
$6.45 (8.54%)
727
Buy Since 09-Aug-2019
$89
$12.69 (16.63%)
$85
22 days ago
(05-Feb-2026)
14/17 (82.35%)
$16.53 (22.81%)
323
Hold Since 05-Feb-2026
$77
$0.69 (0.90%)
$75
22 days ago
(05-Feb-2026)
14/14 (100%)
$4.53 (6.25%)
159
Buy Since 20-Oct-2023
$78
$1.69 (2.21%)
$87
1 months ago
(27-Jan-2026)
6/8 (75%)
$5 (6.85%)
273
Buy Since 17-Feb-2023
$80
$3.69 (4.84%)
$60
1 months 11 days ago
(16-Jan-2026)
3/4 (75%)
$10.36 (14.88%)
397
What Year was the first public recommendation made by Brian Wright?